Published May 30, 1992 | Version v1
Journal article

Myocardial thallium scintigraphy after dipyridamole injection. Application to the diagnosis and evaluation of coronary disease

  • 1. Hopital Avicenne, 93 - Bobigny (France)
  • 2. Institut National de la Sante et de la Recherche Medicale (INSERM) - Hopital Bichat, 75 - Paris (France)

Description

Myocardial thallium scintigraphy performed after intravenous injection of dipyridamole is a non-invasive method to diagnose and evaluate coronary disease.It be used as an alternative to post-exercise scintigraphy, both methods having similar sensitivity and specificity. The dipyridamole test is contraindicated in patients with a history of bronchospasm and uncontrolled angina pectoris. Close clinical and electrocardiographic monitoring is required. The wide use of tomographic techniques has notably improved this examination

Additional details

Additional titles

Original title (French)
Scintigraphie myocardique au thallium apres administration de dipyridamole. Application au diagnostic et a l'evaluation de l'insuffisance coronaire

Publishing Information

Journal Title
Presse Medicale
Journal Volume
21
Journal Issue
20
Journal Page Range
p. 943-947.
ISSN
0032-7867
CODEN
PRMEAI